ESC 365 - Transforming Outcomes for Patients with hATTR Amyloidosis.

Open Access

Transforming Outcomes for Patients with hATTR Amyloidosis.

Session: Transforming Outcomes for Patients with hATTR Amyloidosis

Topic: Cardiac Amyloidosis

Speaker: Doctor C. Whelan (London, GB) Doctor O. Akinboboye (New York, US)

Sponsored by Alnylam Pharmaceuticals

Event: ESC Congress 2021 - The Digital Experience

Congress Session

About the speakers

Doctor Carol Whelan

University College London, London (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

Doctor Ola Akinboboye

New York (United States of America)

1 presentation

0 follower

1 more presentation in this session

Live Q&A session, Meeting Summary & Close.

Access the full session

Transforming Outcomes for Patients with hATTR Amyloidosis

Speakers: Doctor C. Whelan, Doctor O. Akinboboye

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

COVID-19 & digital health: techcelleration here to stay?

22 October 2021

ESC Premium Access

The ESC journey and future directions.

22 October 2021

ESC Premium Access

Amyloidosis, sarcoidosis, other infiltrative diseases and sudden cardiac death.

27 August 2021

This platform is supported by